Belvedere Trading LLC Dyne Therapeutics, Inc. Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024
SELL
$13.06 - $29.18 $430,157 - $961,101
-32,937 Reduced 94.8%
1,807 $51,000
Q4 2023

Feb 13, 2024
BUY
$6.62 - $13.64 $123,701 - $254,877
18,686 Added 116.37%
34,744 $462,000
Q3 2023

Oct 27, 2023
BUY
$8.6 - $12.18 $138,098 - $195,586
16,058 New
16,058 $143,000

Others Institutions Holding DYN

# of Institutions
210
Shares Held
102M
Call Options Held
234K
Put Options Held
238K
View Full List

About Dyne Therapeutics, Inc.

DYN Quotes by TradingView
  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.52B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email